Hikma Pharmaceuticals Share Discussion Threads

[18bt] 22/2/2024 07:02

Latest estimates for 2023: Rev $2850m PTP 522.6m EPS 211.5c Div 48.1c

[hopeful holder] 13/1/2024 21:31

So far, HIK has proven to be better even over this short period.

[hopeful holder] 28/12/2023 10:16

Any researching APH will probably come up with an opinion of, they are not the best by a long way. But... I'm always open to knowing why you think they are better than Hikma.

[blackhorse23] 03/11/2023 00:11

looks like best value healthcare stock is APH

[dartboard1] 02/11/2023 18:31

The Jordanian mafia

[wolfhh] 02/11/2023 17:22

The market do not trust what they say. Clearly a dodgy company

[adamb1978] 02/11/2023 08:06

Decent enough trading statement. PE is only around 12x, which feels very very cheap to me

[dartboard1] 02/11/2023 07:44

One day the EGP will go up... but not this year....

[robertball] 02/11/2023 07:10

Kind of ok

[robertball] 30/8/2023 07:57

Not caught by Us drug announcement yesterday re price controls...

[chc15] 11/8/2023 15:03

Susan did very well.

[robertball] 09/8/2023 07:46

He already works there...

[boadicea] 09/8/2023 07:03

New Injectables big shot announced.

[robertball] 24/7/2023 07:08

How much of a bonus boost will a weakening £ have?

[dartboard1] 20/7/2023 08:29

Oh yeah... says the warehouse had injectables with similar compounds... well that's a stroke of luck

[deanowls] 20/7/2023 08:15

A pzfizer plant taken out in US by a tornado is rumored on Twitter.

[robertball] 20/7/2023 07:53

There has been some sector consolidation in US...so I would guess so

[chc15] 20/7/2023 07:51

Yes, wonder what's caused this, bid rumours?

[dartboard1] 20/7/2023 07:48

Well this is unusual ...

[robertball] 28/4/2023 09:17

I was surprised that the head hunters could not have found somebody from another pharma Co. That's all

[chrysalis99] 28/4/2023 08:45

The family control 27% then there is a list of blue chip instos. There's a huge free float. Things are improving in their markets and this morning's news should lead to upgrades. The valuation is undemanding. The chart looks strong and there is lots of PE interest in Hikma's sector/valuation. Long and strong.

[adamb1978] 28/4/2023 08:39

Hi Robert

Why do you say that the internal candidate was a vote of no confidence?

Agree its overlooked. PE is only around 11x but it generates decent returns and is growing mid single digits so enough places to invest that capital wich it throws off.

Hard to see much downside from here. Agree its not one for speculators as it won't double overnight, but given the starting valuation today its perfectly feasible to this growing 20% say p.a. via a combination of earnings growth and multiple appreciation.

Adam

[robertball] 28/4/2023 08:13

I'm here. This share is overlooked. Sigi's resignation was a bit of a blow and appointing an internal candidate was a vote of no confidence.It's a family firm and it might do OK in the long term.Not for speculators